Antioxidant effects of metronidazole in colonic tissue

M A Pélissier1, P Marteau, P Pochart

  • 1Laboratoire de Biologie, EA-3199, Conservatoire National des Arts et Métiers, 2 rue Conté, 75003 Paris, France. pelissie@cnam.fr

Insights

Metronidazole (MTZ) demonstrates antioxidant effects by reducing oxidative protein damage in the colon. This study provides the first evidence of MTZ

Area of Science:

  • Biochemistry
  • Pharmacology
  • Gastroenterology

Background:

  • Reactive oxygen species (ROS) contribute to tissue injury in inflammatory bowel diseases (IBD).
  • Metronidazole (MTZ) may possess antioxidant properties beyond its antibiotic effects in IBD treatment.
  • Oxidative stress biomarkers include protein carbonyls, malondialdehyde, and glutathione levels.

Purpose of the Study:

  • To evaluate the antioxidant potential of metronidazole (MTZ) on oxidative damage biomarkers in rat gastrointestinal tissues and liver.
  • To investigate the effect of MTZ on protein carbonyls, malondialdehyde, and glutathione levels under physiological conditions.

Main Methods:

  • Controlled study involving MTZ-treated and control rats.
  • Measurement of protein carbonyls, malondialdehyde, and glutathione levels in the small intestine, large intestine (colon), and liver.
  • Assessment of oxidative damage and antioxidant defense under physiological conditions.

Main Results:

  • Basal levels of protein carbonyls and malondialdehyde were significantly higher in the colon than in the small intestine.
  • MTZ significantly reduced oxidative protein damage (protein carbonyls) in the colon.
  • MTZ did not cause any adverse side effects on liver biomarkers.

Conclusions:

  • Metronidazole exhibits a significant antioxidant effect on oxidative protein damage in the colon.
  • This study provides the first evidence of MTZ's antioxidant activity on colonic protein damage under physiological conditions.
  • MTZ's efficacy in certain IBD cases may be partly attributed to its antioxidant properties.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...